Literature DB >> 12937771

Action of Trypanosoma rangeli in infections with virulent Trypanosoma cruzi populations.

M T Paláu1, A J Mejía, U Vergara, C A Zúñiga.   

Abstract

In experimental murine infections with Trypanosoma rangeli it has been observed development immune response to Trypanosoma cruzi. The aim of the present work was to analyze the result of antigenic stimuli and the protective effect with T. rangeli in T. cruzi infections. Mice groups immunized with metacyclic trypomastigotes of T. rangeli (Choach -2V strain), derived from haemolymph and salivary gland and reinfected with T. cruzi virulent populations (Tulahuen strain, SA strain and Dm28c clone) from infected in vitro cells, showed decrease severity of disease outcomes, low parasitemia levels and 100% survival of all mice immunized, in comparison with groups infected only with T. cruzi populations, which demonstrated tissue affection, high parasitemia levels and the death of all animals. The above mentioned data contribute to understand the biological behaviour of T. cruzi and T. rangeli and their interaction with vertebrate host.

Entities:  

Mesh:

Year:  2003        PMID: 12937771     DOI: 10.1590/s0074-02762003000400022

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  6 in total

1.  Human trypanosomiasis in the eastern region of the Panama Province: new endemic areas for Chagas disease.

Authors:  José E Calzada; Vanesa Pineda; Juan D Garisto; Franklyn Samudio; Ana Maria Santamaria; Azael Saldaña
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

Review 2.  Modulation of immune response in experimental Chagas disease.

Authors:  Beatriz Basso
Journal:  World J Exp Med       Date:  2013-02-20

3.  Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.

Authors:  Zuleima C Caballero; Octavio E Sousa; Waldelania P Marques; Amadeo Saez-Alquezar; Eufrosina S Umezawa
Journal:  Clin Vaccine Immunol       Date:  2007-05-23

Review 4.  American trypanosomiasis, or Chagas disease, in Panama: a chronological synopsis of ecological and epidemiological research.

Authors:  Indra G Rodriguez; Jose R Loaiza
Journal:  Parasit Vectors       Date:  2017-10-10       Impact factor: 3.876

5.  A systematic review of the diagnostic aspects and use of Trypanosoma rangeli as an immunogen for Trypanosoma cruzi infection.

Authors:  Taciana de Souza Bayão; Marli do Carmo Cupertino; Nicholas Alfred Joseph Mayers; Rodrigo Siqueira-Batista
Journal:  Rev Soc Bras Med Trop       Date:  2020-09-11       Impact factor: 1.581

6.  Vaccination with Trypanosoma rangeli reduces the infectiousness of dogs experimentally infected with Trypanosoma cruzi.

Authors:  Beatriz Basso; Irma Castro; Virginia Introini; Patricia Gil; Carine Truyens; Edgardo Moretti
Journal:  Vaccine       Date:  2007-03-08       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.